BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2081779)

  • 1. High-performance liquid chromatographic determination of diacetolol enantiomers.
    Piquette-Miller M; Foster RT
    J Chromatogr; 1990 Nov; 533():300-3. PubMed ID: 2081779
    [No Abstract]   [Full Text] [Related]  

  • 2. Enantioselective high performance liquid chromatographic assay of acebutolol and its active metabolite diacetolol in human serum.
    Szymura-Oleksiak J; Walczak M; Bojarski J; Aboul-Enein HY
    Chirality; 1999; 11(4):267-71. PubMed ID: 10224653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acebutolol and diacetolol: their binding to plasma proteins and erythrocytes and secretion with the saliva].
    Kukes VG; Gneushev ET; Mamedov TSh; Gneusheva IA
    Farmakol Toksikol; 1991; 54(1):53-5. PubMed ID: 1860501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-automated high-performance liquid chromatographic method for the determination of diacetolol hydrochloride in medicated animal diets.
    Bowker MJ; Gladwin RP; Mills DJ; Stubbles JA
    J Chromatogr; 1980 Nov; 200():261-6. PubMed ID: 7451607
    [No Abstract]   [Full Text] [Related]  

  • 5. Separation of acebutolol and diacetolol diastereomers by reversed-phase high-performance liquid chromatography.
    Gulaid AA; Houghton GW; Boobis AR
    J Chromatogr; 1985 Jan; 318(2):393-7. PubMed ID: 3980629
    [No Abstract]   [Full Text] [Related]  

  • 6. Stereospecific high-performance liquid chromatographic assay of acebutolol in human plasma and urine.
    Piquette-Miller M; Foster RT; Pasutto FM; Jamali F
    J Chromatogr; 1990 Mar; 526(1):129-37. PubMed ID: 2341525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-pressure liquid chromatographic analysis of drugs in biological fluids. V. Analysis of acebutolol and its major metabolite.
    Meffin PJ; Harapat SR; Yee YG; Harrison DC
    J Chromatogr; 1977 Aug; 138(1):183-91. PubMed ID: 893593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversed-phase high-performance liquid chromatography with differential pulse polarographic detection for assaying drugs in feed: stability-indicating assay of diacetolol.
    Schieffer GW
    J Chromatogr; 1980 Dec; 202(3):405-12. PubMed ID: 7462373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using supported liquid extraction together with cellobiohydrolase chiral stationary phases-based liquid chromatography with tandem mass spectrometry for enantioselective determination of acebutolol and its active metabolite diacetolol in spiked human plasma.
    Jiang H; Randlett C; Junga H; Jiang X; Ji QC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):173-80. PubMed ID: 19109073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method.
    Sankey MG; Gulaid A; Kaye CM
    J Pharm Pharmacol; 1984 Apr; 36(4):276-7. PubMed ID: 6144783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitive method for the determination of acebutolol and its N-acetyl metabolite in biological media by high performance liquid chromatography and fluorescence detection].
    Roux A; Flouvat B
    J Chromatogr; 1978 Dec; 166(1):327-32. PubMed ID: 744784
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.
    Zaman R; Jack DB; Wilkins MR; Kendall MJ
    Biopharm Drug Dispos; 1985; 6(2):131-7. PubMed ID: 4005393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cimetidine co-administration on the pharmacokinetics of acebutolol enantiomers and its metabolite diacetolol in a rat model: the effect of gastric pH on double-peak phenomena.
    Mostafavi SA; Foster RT
    Int J Pharm; 2003 Apr; 255(1-2):81-6. PubMed ID: 12672604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of acebutolol and its main metabolite, diacetolol after oral administration of acebutolol in rabbits with carbon tetrachloride-induced hepatic failure.
    Choi JS; Burm JP
    Arch Pharm Res; 2002 Aug; 25(4):541-5. PubMed ID: 12214869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood plasma binding of acebutolol and diacetolol in man.
    Coombs TJ; Coulson CJ; Smith VJ
    Br J Clin Pharmacol; 1980 Apr; 9(4):395-7. PubMed ID: 7378256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acebutolol and diacetolol plasma levels in patients undergoing myocardial revascularization with hypothermic cardiopulmonary bypass.
    Mantz J; Blanchot G; Marty J; Farinotti R; Trouvin JH; Hazebroucq J; Desmonts JM
    J Cardiothorac Anesth; 1990 Oct; 4(5):577-81. PubMed ID: 2132136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic study of acebutolol in aged subjects as compared to young subjects.
    Roux A; Henry JF; Fouache Y; Chau NP; Hervy MP; Forette F; Bourdarias JP; Flouvat B
    Gerontology; 1983; 29(3):202-8. PubMed ID: 6852547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of grapefruit juice on the pharmacokinetics of acebutolol.
    Lilja JJ; Raaska K; Neuvonen PJ
    Br J Clin Pharmacol; 2005 Dec; 60(6):659-63. PubMed ID: 16305592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatography assay of acebutolol and two of its metabolites in plasma and urine.
    Buskin JN; Upton RA; Jones RM; Williams RL
    J Chromatogr; 1982 Jul; 230(2):438-42. PubMed ID: 7107789
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations on the clinical pharmacology and plasma concentrations of diacetolol, the major human metabolite of acebutolol.
    Ohashi K; Warrington SJ; Kaye CM; Houghton GW; Dennis M; Templeton R; Turner P
    Br J Clin Pharmacol; 1981 Oct; 12(4):561-5. PubMed ID: 7295489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.